|
|
A PLATFORM TRIAL DESIGN TO ACCELERATE TRANSLATIONAL THERAPIES IN A CANINE DISEASE MODEL OF ALS |
| 5R21TR002277-02 |
COATES, JOAN RIPLEY |
NCATS |
2019 |
|
|
COMMERCIALIZATION OF A SOFTWARE PLATFORM TO INCREASE THE EFFICIENCY OF HUMAN CLINICAL TRIALS USING PATIENT-LEVEL MACHINE LEARNING MODELS |
| 5R44TR002047-03 |
ENNIST, DAVID L |
NCATS |
2019 |
|
|
TISSUE-SPECIFIC MODULATION OF APOLIPOPROTEIN E IN NEURODEGENERATION |
| 1F30AG066373-01 |
FERGUSON, CHANTAL |
NIA |
2019 |
|
|
IMPEDING TRANSCRIPTION OF EXPANDED MICROSATELLITE REPEATS USING DEACTIVATED CAS9 |
| 1R01AG058636-01A1 |
WANG, ERIC T |
NIA |
2019 |
|
|
NOVEL PROTEIN AGGREGATION INHIBITORS AND UPPER MOTOR NEURON STABILIZERS FOR ALS AND OTHER NEURODEGENERATIVE DISEASES |
| 1R01AG061708-01A1 |
OZDINLER, PEMBE HANDE |
NIA |
2019 |
|
|
RESISTANCE AND VULNERABILITY FOR ALZHEIMER'S AND RELATED PATHOLOGIES |
| 1R56AG058732-01A1 |
MCMILLAN, COREY T |
NIA |
2019 |
|
|
MITOCHONDRIAL TDP-43 IN ALZHEIMER'S DISEASE |
| 1RF1AG056320-01A1 |
WANG, XINGLONG |
NIA |
2019 |
|
|
NOVEL GENETIC MODIFIERS OF C9ORF72 AND TAU TOXICITY |
| 1RF1AG062077-01 |
FRYER, JOHN DAVID |
NIA |
2019 |
|
|
GENETIC ETIOLOGY OF AMYOTROPHIC LATERAL SCLEROSIS |
| 1ZIAAG000933-12 |
TRAYNOR, BRYAN |
NIA |
2019 |
|
|
GENETIC ETIOLOGY OF FRONTO-TEMPORAL DEMENTIA, A DEMENTIA RELATED TO ALZHEIMERS DISEASE |
| 1ZIAAG000934-11 |
TRAYNOR, BRYAN |
NIA |
2019 |
